MarketBeat Instant News Alerts 2 hours agoOndas (NASDAQ:ONDS) Stock Rated "Market Outperform" in New Coverage at Citizens JmpMarketBeatCitizens Jmp began coverage on Ondas in a report on Monday. They set a "market outperform" rating and a $14.00 target price on the stock.NASDAQ:ONDSRead Ondas (NASDAQ:ONDS) Stock Rated "Market Outperform" in New Coverage at Citizens Jmp2 hours agoMillrose Properties' (MRP) "Market Perform" Rating Reaffirmed at Citizens JmpMarketBeatCitizens Jmp reaffirmed a "market perform" rating on shares of Millrose Properties in a research report on Monday.NYSE:MRPRead Millrose Properties' (MRP) "Market Perform" Rating Reaffirmed at Citizens Jmp2 hours agoBank of America Upgrades DraftKings (NASDAQ:DKNG) to BuyMarketBeatBank of America upgraded shares of DraftKings from a "neutral" rating to a "buy" rating and set a $27.00 target price for the company in a research report on Monday.NASDAQ:DKNGRead Bank of America Upgrades DraftKings (NASDAQ:DKNG) to Buy2 hours agoRentokil Initial (NYSE:RTO) Stock Rating Upgraded by Stifel NicolausMarketBeatStifel Nicolaus raised shares of Rentokil Initial from a "hold" rating to a "buy" rating in a report on Monday.NYSE:RTORead Rentokil Initial (NYSE:RTO) Stock Rating Upgraded by Stifel Nicolaus2 hours agoBristol Myers Squibb (NYSE:BMY) Cut to "Market Perform" at Leerink PartnersMarketBeatLeerink Partners cut shares of Bristol Myers Squibb from an "outperform" rating to a "market perform" rating and set a $59.00 target price for the company. in a research note on Monday.NYSE:BMYRead Bristol Myers Squibb (NYSE:BMY) Cut to "Market Perform" at Leerink Partners2 hours agoLB Pharmaceuticals (NASDAQ:LBRX) Rating Lowered to "Neutral" at Roth CapitalMarketBeatRoth Capital cut shares of LB Pharmaceuticals from a "buy" rating to a "neutral" rating and set a $35.00 target price for the company. in a research note on Monday.NASDAQ:LBRXRead LB Pharmaceuticals (NASDAQ:LBRX) Rating Lowered to "Neutral" at Roth Capital Trending News1Advanced Micro Devices (NASDAQ:AMD) Stock Lifted to "Buy" by Wall Street Zen2NIKE Q1 Earnings Call Highlights3Rocket Lab (NASDAQ:RKLB) Stock Jumps 6.2% - Here's Why4IREN (NASDAQ:IREN) Stock Falls 1.2% on Analyst Downgrade5Cerebras Systems (NASDAQ:CBRS) Shares Gap Down - Here's What Happened6Oracle (NYSE:ORCL) Given Market Outperform Rating at Citizens Jmp7TELUS (TSE:T) Stock Price Target Cut by National Bank Financial8The Home Depot, Inc. (NYSE:HD) Stock Has Consensus Target Price of $375.18 According to Brokerages All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoSphere Entertainment (NYSE:SPHR) Downgraded by Craig Hallum to "Hold"MarketBeatNYSE:SPHRRead Sphere Entertainment (NYSE:SPHR) Downgraded by Craig Hallum to "Hold"2 hours agouniQure (NASDAQ:QURE) Cut to Equal Weight at BarclaysMarketBeatNASDAQ:QURERead uniQure (NASDAQ:QURE) Cut to Equal Weight at Barclays2 hours agoRyder System (NYSE:R) Stock Rating Raised to Overweight at JPMorgan Chase & Co.MarketBeatNYSE:RRead Ryder System (NYSE:R) Stock Rating Raised to Overweight at JPMorgan Chase & Co.2 hours agoStephens Issues Pessimistic Forecast for Atlas Energy Solutions (NYSE:AESI) Stock PriceMarketBeatNYSE:AESIRead Stephens Issues Pessimistic Forecast for Atlas Energy Solutions (NYSE:AESI) Stock Price2 hours agoNucor (NYSE:NUE) Given New $286.00 Price Target at KeyCorpMarketBeatNYSE:NUERead Nucor (NYSE:NUE) Given New $286.00 Price Target at KeyCorp2 hours agoReliance (NYSE:RS) Stock Price Target Raised at KeyCorpMarketBeatNYSE:RSRead Reliance (NYSE:RS) Stock Price Target Raised at KeyCorp2 hours agoVirtu Financial (NYSE:VIRT) Stock Rating Upgraded by JPMorgan Chase & Co.MarketBeatNYSE:VIRTRead Virtu Financial (NYSE:VIRT) Stock Rating Upgraded by JPMorgan Chase & Co.2 hours agoAgenus (NASDAQ:AGEN) Stock Keeps "Buy" Rating at Chardan CapitalMarketBeatNASDAQ:AGENRead Agenus (NASDAQ:AGEN) Stock Keeps "Buy" Rating at Chardan Capital2 hours agoLifeStance Health Group (NASDAQ:LFST) Stock Price Target Raised at KeyCorpMarketBeatNASDAQ:LFSTRead LifeStance Health Group (NASDAQ:LFST) Stock Price Target Raised at KeyCorp2 hours agoLumentum's (LITE) Buy Rating Reaffirmed at Rosenblatt SecuritiesMarketBeatNASDAQ:LITERead Lumentum's (LITE) Buy Rating Reaffirmed at Rosenblatt Securities2 hours agoMorgan Advanced Materials (LON:MGAM) Hits New 12-Month High - Time to Buy?MarketBeatLON:MGAMRead Morgan Advanced Materials (LON:MGAM) Hits New 12-Month High - Time to Buy?2 hours agoHovde Group Initiates Coverage on Southern Missouri Bancorp (NASDAQ:SMBC)MarketBeatNASDAQ:SMBCRead Hovde Group Initiates Coverage on Southern Missouri Bancorp (NASDAQ:SMBC)2 hours agoHovde Group Begins Coverage on Avidia Bancorp (NYSE:AVBC)MarketBeatNYSE:AVBCRead Hovde Group Begins Coverage on Avidia Bancorp (NYSE:AVBC)2 hours agoBMO Capital Markets Has Lowered Expectations for CareTrust REIT (NYSE:CTRE) Stock PriceMarketBeatNYSE:CTRERead BMO Capital Markets Has Lowered Expectations for CareTrust REIT (NYSE:CTRE) Stock Price2 hours agoDTE Energy (NYSE:DTE) Given New $134.00 Price Target at BMO Capital MarketsMarketBeatNYSE:DTERead DTE Energy (NYSE:DTE) Given New $134.00 Price Target at BMO Capital Markets2 hours agoGain Therapeutics' (GANX) "Buy" Rating Reaffirmed at HC WainwrightMarketBeatNASDAQ:GANXRead Gain Therapeutics' (GANX) "Buy" Rating Reaffirmed at HC Wainwright2 hours agoMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stock Has Average Price Target of $6.83MarketBeatNASDAQ:MRVIRead Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stock Has Average Price Target of $6.832 hours agoCAMP4 Therapeutics (NASDAQ:CAMP) Coverage Initiated by Analysts at OppenheimerMarketBeatNASDAQ:CAMPRead CAMP4 Therapeutics (NASDAQ:CAMP) Coverage Initiated by Analysts at Oppenheimer2 hours agoWorkday (NASDAQ:WDAY) Earns "Buy" Rating from Needham & Company LLCMarketBeatNASDAQ:WDAYRead Workday (NASDAQ:WDAY) Earns "Buy" Rating from Needham & Company LLC2 hours agoHSBC Upgrades Grupo Aeroportuario Del Pacifico (NYSE:PAC) to BuyMarketBeatNYSE:PACRead HSBC Upgrades Grupo Aeroportuario Del Pacifico (NYSE:PAC) to Buy2 hours agoOxford Industries (NYSE:OXM) Stock Rating Reaffirmed as Neutral by BTIG ResearchMarketBeatNYSE:OXMRead Oxford Industries (NYSE:OXM) Stock Rating Reaffirmed as Neutral by BTIG Research2 hours agoVerastem (NASDAQ:VSTM) Given Buy Rating at BTIG ResearchMarketBeatNASDAQ:VSTMRead Verastem (NASDAQ:VSTM) Given Buy Rating at BTIG Research2 hours agoSagimet Biosciences (NASDAQ:SGMT) Stock Rating Reaffirmed as "Buy" by HC WainwrightMarketBeatNASDAQ:SGMTRead Sagimet Biosciences (NASDAQ:SGMT) Stock Rating Reaffirmed as "Buy" by HC Wainwright2 hours agoGenerate Biomedicines' (GENB) Buy Rating Reiterated at HC WainwrightMarketBeatNASDAQ:GENBRead Generate Biomedicines' (GENB) Buy Rating Reiterated at HC Wainwright Featured Articles and OffersDeutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?By Sam Quirke | September 30, 2026Trump's New DollarFrom Porter & Company (Ad)Six Flags Launches FlexPay—Is There Any FUN Left in the Stock?By Chris Markoch | September 28, 2026Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam?By Thomas Hughes | October 4, 2026Everyone in AI Is Quietly Copying Palantir's PlaybookBy Chris Markoch | October 1, 2026Record-High Copper Ignites District-Scale Discovery Below $2From Resource Stock Digest (Ad)CarMax Just Gave Investors a Better Reason to Believe in the TurnaroundBy Thomas Hughes | September 29, 2026Brewing Trouble? Starbucks Spills the Beans on 250 Store ClosuresBy Jeffrey Neal Johnson | September 28, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 151 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
